Kodiak Sciences Inc.
NASDAQ:KODBiotechnology
Healthcare
$97.90 -0.08%
-$0.03 today
- Market cap
- $6.40B
- Beta
- 2.21
- P/E (TTM)
- -9.6
- EPS (TTM)
- -$3.73
52W Low $3.43High $47.84
Volume 0.52M
Average 1.10M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$136.01M
FY 2025 · Annual
Investing Cash Flow
-$506,000.00
FY 2025 · Annual
Financing Cash Flow
$178.30M
FY 2025 · Annual
+35489.2% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (266.99M) | (333.82M) | (260.49M) | (176.21M) | (229.97M) |
| Depreciation & Amortization | 8.71M | 11M | 25.95M | 26.71M | 26.32M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 61.39M | 106.03M | 88.56M | 60.21M | 58.86M |
| Change in Working Capital | 14.43M | 11.96M | (7.36M) | (28.39M) | 6.85M |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (2.09M) | 1.66M | 5.6M | (9.69M) | 8.07M |
| Other Working Capital | 16.52M | 10.3M | (12.95M) | (18.69M) | (1.22M) |
| Other Non-Cash Items | 198K | (1.63M) | (840K) | 355K | 1.93M |
| Operating Cash Flow | (182.27M) | (206.46M) | (154.18M) | (117.32M) | (136.01M) |
| Capital Expenditures | (63.3M) | (47.36M) | (41.43M) | (400K) | (506K) |
| Acquisitions (Net) | 0 | 0 | (290.65K) | 0 | 0 |
| Purchases of Investments | 0 | (427.77M) | (49.35M) | (355K) | 0 |
| Sales of Investments | 24.5M | 138M | 340M | 0 | 0 |
| Other Investing Activities | 0 | 616K | 290.65K | 0 | 0 |
| Investing Cash Flow | (38.8M) | (336.51M) | 249.23M | (755K) | (506K) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 8.23M | 1.94M | 242K | 501K | 178.3M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (45K) | (49K) | (211K) | 0 | 0 |
| Financing Cash Flow | 8.18M | 1.9M | 31K | 501K | 178.3M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (212.89M) | (541.08M) | 95.07M | (117.57M) | 41.79M |
| Free Cash Flow | (245.57M) | (253.82M) | (195.61M) | (117.72M) | (136.51M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$230.0M
+ D&A$26.3M
+ Stock-Based Comp$58.9M
+ Deferred Tax$0
+ Working Capital$6.8M
+ Other Non-Cash$1.9M
= Operating Cash Flow-$136.0M
- Capex-$506.0K
= Free Cash Flow-$136.5M
Analysis
FY2025 free cash flow is -$136.5M. FCF conversion is 59.4% of net income. Operating cash flow was -$136.0M, with capex of -$506.0K. The largest bridge item is Stock-Based Comp at $58.9M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 12, 2026 | |
| 10-Q | Quarterly report | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 6, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 26, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 23, 2026 |
Does KOD generate free cash flow?
Kodiak Sciences Inc. (KOD) generated -$136.51M of free cash flow in fiscal 2025.
How much operating cash flow does KOD produce?
Operating cash flow was -$136.01M, before capital expenditures of $506,000.00.
Continue the stock analysis
Jump to another research area for this company.